Literature DB >> 19740327

Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments.

Morten Løbner1, Robert G Q Leslie, Wolfgang M Prodinger, Claus H Nielsen.   

Abstract

While our previous studies have demonstrated that complement activation induced by complement receptors type 2 (CR2/CD21) and 1 (CR1/CD35) results in C3-fragment deposition and membrane attack complex (MAC) formation in human B cells, the consequences of these events for B-cell functions remain unknown. In the present study, we show that CR2-induced complement activation results in membrane depolarization, as indicated by annexin V binding, with kinetics similar to those of C3-fragment deposition and different from those of MAC formation. On the other hand, like MAC formation, depolarization requires activation of complement via the alternative pathway, as indicated by total inhibition upon neutralization of factor D, and is abrogated by combined blockade of CR1 and CR2, but not of either receptor alone. The membrane depolarization is not associated with the apoptosis of B cells, as examined by co-staining with APO-2.7 or by the TdT-mediated biotin-dUTP nick-end labelling (TUNEL) assay. Confocal microscopy revealed that depolarization and C3 deposition, unlike MAC deposition, are limited to restricted areas on the B-cell surface. Double staining revealed a close association between the C3-fragment patches and membrane depolarization, as well as redistribution of lipid rafts to these areas. We propose that these events may play a role in the regulation of B-cell signalling and cross-talk with T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740327      PMCID: PMC2753917          DOI: 10.1111/j.1365-2567.2009.03056.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells.

Authors:  R G Leslie
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

Review 2.  Role of the C5b-9 complement complex in cell cycle and apoptosis.

Authors:  H G Rus; F I Niculescu; M L Shin
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

3.  The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.

Authors:  Claus Henrik Nielsen; Morten Løbner Pedersen; Hanne Vibeke Marquart; Wolfgang Maria Prodinger; Robert Graham Quinton Leslie
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

4.  CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytes.

Authors:  C H Nielsen; H V Marquart; W M Prodinger; R G Leslie
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

5.  The terminal complement complex C5b-9 stimulates interleukin-6 production in human smooth muscle cells through activation of transcription factors NF-kappa B and AP-1.

Authors:  C Viedt; G M Hänsch; R P Brandes; W Kübler; J Kreuzer
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

6.  Terminal complement complex C5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization.

Authors:  Yongwen Chen; Chengying Yang; Naishi Jin; Zhunyi Xie; Yuyu Tang; Lei Fei; Zhengcai Jia; Yuzhang Wu
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

7.  Annexin V binds to positively selected B cells.

Authors:  S R Dillon; A Constantinescu; M S Schlissel
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

8.  The terminal complement complex inhibits apoptosis in vascular smooth muscle cells by activating an autocrine IGF-1 loop.

Authors:  Thomas P Zwaka; Jan Torzewski; Andreas Hoeflich; Marion Déjosez; Steffen Kaiser; Vinzenz Hombach; Peter M Jehle
Journal:  FASEB J       Date:  2003-05-20       Impact factor: 5.191

9.  Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype.

Authors:  Claudia Kemper; Andrew C Chan; Jonathan M Green; Kelly A Brett; Kenneth M Murphy; John P Atkinson
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

10.  A role for lipid rafts in B cell antigen receptor signaling and antigen targeting.

Authors:  P C Cheng; M L Dykstra; R N Mitchell; S K Pierce
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

View more
  3 in total

1.  Reaction of complement factors varies with prion strains in vitro and in vivo.

Authors:  Rie Hasebe; Gregory J Raymond; Motohiro Horiuchi; Byron Caughey
Journal:  Virology       Date:  2012-01-03       Impact factor: 3.616

2.  Interaction of Serum-Derived and Internalized C3 With DNA in Human B Cells-A Potential Involvement in Regulation of Gene Transcription.

Authors:  Mariann Kremlitzka; Alicja A Nowacka; Frida C Mohlin; Pradeep Bompada; Yang De Marinis; Anna M Blom
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

3.  The Sez6 Family Inhibits Complement by Facilitating Factor I Cleavage of C3b and Accelerating the Decay of C3 Convertases.

Authors:  Wen Q Qiu; Shaopeiwen Luo; Stefanie A Ma; Priyanka Saminathan; Herman Li; Jenny M Gunnersen; Harris A Gelbard; Jennetta W Hammond
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.